Recent events

Tyenne arthritis injection vials recalled nationwide over glass particles

The FDA warned that 400 mg/20 mL Tyenne (tocilizumab-aazg) injection vials, lot 16UI07, are being recalled nationwide after an internal investigation at the manufacturer found glass particles in the affected vials. The FDA said administering a recalled vial can cause local irritation, pain or swelling at the infusion site, vein inflammation, and in serious cases blocked blood flow, pulmonary embolism, permanent organ damage or death. No injuries or illnesses had been reported at the time.